Harbin Medisan Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 966.463 million compared to CNY 1,631.127 million a year ago. Operating income was CNY 31.296 million compared to CNY 200.283 million a year ago. Net income was CNY 22.160 million compared to CNY 150.760 million a year ago. Basic earnings per share from continuing operations was CNY 0.07 compared to CNY 0.48 a year ago.